Stock quote - Summary

Abaco Capital Ord 0.001p
ABA: 1.47 0.00 ( 0.00 %) delayed: 17:15PM
Bid price 1.45 High price 0.00
Ask price 1.55 Low price 0.00
Open price 0.00 Spread 0.00%
Prev close 1.50 Volume 0

Abaco Capital Ord 0.001p - Share price charts

Intraday
Historic - 6 months

Advanced Abaco Capital Ord 0.001p charts >

Abaco Capital Ord 0.001p - Share price information
Name Abaco Capital Ord 0.001p Epic ABA
Activities Abaco Capital plc (formerly Oxford Pharmascience Group plc, formerly Oxford Nutrascience plc) following completion of the Demerger of its former subsidiary Oxford Pharmascience Limited, the Company is now classified as an AIM Rule 15 Cash Shell and as such will be required to make an acquisition or acquisitions which constitutes a reverse takeover under Rule 14 of the AIM Rules (including seeking re-admission as an investing company, as defined under the AIM Rules) on or before the date falling six months from completion of the Demerger. In seeking and considering potential acquisitions, the Board of Directors intends to identify opportunities offering the potential to deliver value creation and returns to shareholders over the medium to long-term. The Company will consider investment opportunities in any sectors as they arise, however, the Board of Directors have a combined skill set and experience particular to the pharmaceutical, biotechnology and technology sectors. ISIN GB00B3LXPB43
Latest Share Price (p) 0.00 Net Gearing (%) -98.58
Market Capitalisation (pm) 18.09 Gross Gearing (%) 1.28
Shares in issue (m) 1,205.66 Debt Ratio 0.00
P/E Ratio -11.54 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.01
Dividend Yield (%) 0.00 Price to book value 0.95
Dividend Cover 0.00 ROCE (%) -2.74
Earning per share (p) -0.13 EPS Growth (%) -18.18
52-week high / low (p) 1.73 / 1.15 DPS Growth (%) n/a

Risk warning: Remember the price of shares can go down as well as up, and you are not guaranteed to get back the amount that you originally invested.
Click here to read the full warning.